1 BTC
=
- USD
TransMedics Group, Inc. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About TransMedics Group, Inc. Common Stock
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Market Statistics
Trading Metrics
How to Buy TMDX
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy TMDX
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesShort sellers are heavily targeting 10 stocks with short interest exceeding 40% of float. Choice Hotels and Avis Budget lead with over 50% short interest, while Lucid Group, Hertz Global, and crypto/semiconductor plays like Marathon Digital and CleanSpark also face significant bearish positioning. Traders are watching for potential squeeze opportunities if positive catalysts emerge.
TransMedics Group has surged 104% over the past year as it dominates the organ transplant industry with its innovative Organ Care System and National OCS Program. Despite trading at a premium 56x forward earnings and facing significant short interest (25% of float), the company's strong growth (32% quarterly sales growth), expanding moat through vertical integration, and international expansion opportunities suggest the valuation may be justified for long-term investors.
Joby Aviation's stock has fallen 25% year-to-date and is trading 50% below 2025 highs at $9.56. While the lower price may seem attractive, the company's $9.4 billion market cap is still higher than established competitors like American Airlines, Lyft, and TransMedics despite having no commercial operations yet. The analyst recommends caution, noting the stock appears priced for perfection given Joby's unproven eVTOL air taxi business model and pending FAA certification.
TransMedics Group (TMDX) is revolutionizing organ transplantation with its Organ Care System (OCS), which significantly improves organ utilization rates compared to traditional cold storage methods. The company has shown strong financial growth and recently built its own dedicated aircraft transportation network to address logistics challenges. However, investors should be aware of regulatory risks and the high costs of maintaining its fleet.
The article identifies 10 heavily shorted stocks that could be potential short squeeze targets as of February 2, 2026. It explains how short squeezes work as a volatile feedback loop where rising stock prices force short sellers to cover positions, creating explosive gains. The most shorted stocks include Choice Hotels (56.33%), Lucid Group (54.45%), and Avis Budget Group (52.38%), among others. The article cautions that while monitoring short interest can help identify squeeze opportunities, timing such trades is extremely challenging and investors should conduct due diligence as volatility often reflects underlying business risks.
